000 | 01831 a2200469 4500 | ||
---|---|---|---|
005 | 20250514192051.0 | ||
264 | 0 | _c20050825 | |
008 | 200508s 0 0 eng d | ||
022 | _a0954-6928 | ||
024 | 7 |
_a10.1097/00019501-200402000-00010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSethi, Rajat | |
245 | 0 | 0 |
_aImprovement of cardiac function and beta-adrenergic signal transduction by propionyl L-carnitine in congestive heart failure due to myocardial infarction. _h[electronic resource] |
260 |
_bCoronary artery disease _cFeb 2004 |
||
300 |
_a65-71 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenylyl Cyclases _xdrug effects |
650 | 0 | 4 |
_aAdrenergic beta-Agonists _xpharmacology |
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
650 | 0 | 4 |
_aCarnitine _xanalogs & derivatives |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aGTP-Binding Proteins _xdrug effects |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 |
_aIsoproterenol _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aModels, Cardiovascular |
650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Adrenergic, beta _xdrug effects |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aStroke Volume _xdrug effects |
650 | 0 | 4 |
_aVentricular Function _xdrug effects |
700 | 1 | _aWang, Xi | |
700 | 1 | _aFerrari, Roberto | |
700 | 1 | _aDhalla, Naranjan S | |
773 | 0 |
_tCoronary artery disease _gvol. 15 _gno. 1 _gp. 65-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00019501-200402000-00010 _zAvailable from publisher's website |
999 |
_c14907730 _d14907730 |